In nutra the payout is working capital. Yesterday's commission is today's ad spend — and a partner waiting on net-30 through a bank simply buys less traffic for you, or takes the campaign to an advertiser who pays on Friday.
Buyers expect weekly, sometimes faster. Every extra payment run multiplies wire fees and manual work, so finance pushes back to monthly — and your acquisition team loses the argument with the partner.
Supplement and peptide advertising is treated as high-risk by acquirers and by receiving banks alike. Your revenue arrives with a reserve on it, and your partner's inbound transfer arrives with a question attached.
Partners rotate fast, deals are agreed in chat, adjustments for chargebacks and returns get applied informally. Six months later nobody can show which agreement a given transfer discharged — or who was actually behind the account.
Cost per counterparty doesn't scale with the number of payments, so a weekly cycle costs you what a monthly one used to. Approve, credit, done.
Funds are spendable at the moment they're credited. Your partner's cash cycle shortens, which shows up in your volume, not just their gratitude.
Chargeback and return deductions are shown in the period calculation the partner sees and you approve — not renegotiated in a chat window after the fact.
Nobody receives a card without identity verification, so high partner churn stops eroding the quality of your counterparty records.
Every day a commission sits unpaid is a day your partner isn't buying traffic for you.